Wu S
National Research Institute for Family Planning, Beijing.
J Am Med Womens Assoc (1972). 2000;55(3 Suppl):197-9, 204.
This paper reviews the literature on early medical abortion in China. Mifepristone was approved for termination of pregnancy up to 49 days' gestation in China in 1986. The commonly accepted regimens are 150 mg mifepristone administered in several small doses or a single 200 mg dose followed by 0.6 mg oral misoprostol. Complete abortion rates are 90% to 97%. Ultrasound is strongly recommended to rule out ectopic pregnancy. Patients remain in the clinic for four to six hours after misoprostol. If the fetal sac is not expelled during the four-hour observation, the second dose of 0.4 mg misoprostol is given in many of the clinics. Rates of emergency curettage ranged from less than 1% to 4%, and rates of blood transfusion were less than 1%. The major complication of concern is undiagnosed ectopic pregnancy. The Chinese experience has shown that medical abortion is well accepted as an alternative to surgical intervention when provided under medical supervision and administrative monitoring.
本文综述了中国早期药物流产的相关文献。1986年,米非司酮在中国被批准用于终止妊娠49天内的妊娠。常用方案是分几次小剂量服用150毫克米非司酮或单次服用200毫克,随后口服0.6毫克米索前列醇。完全流产率为90%至97%。强烈建议进行超声检查以排除异位妊娠。患者在服用米索前列醇后在诊所留观四至六小时。如果在四小时观察期内孕囊未排出,许多诊所会给予第二剂0.4毫克米索前列醇。急诊刮宫率在不到1%至4%之间,输血率不到1%。主要关注的并发症是未诊断出的异位妊娠。中国的经验表明,在医疗监督和行政监管下,药物流产作为手术干预的替代方法被广泛接受。